Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 11Thoracic 2Other solid neoplasm 1CNS 1Breast 1

Conditions

Mesothelioma, Malignant 5Unspecified Adult Solid Tumor, Protocol Specific 3Mesothelioma 3Solitary Fibrous Tumor, Pleural 1Recurrence 1Malignant Solid Tumour 1Carcinoma, Non-Small-Cell Lung 1Advanced Solid Tumors 1Advanced Malignant Solid Tumors 1

Interventions

vandetanib 1niraparib 1alvocidib 1Vinorelbine 1Topotecan 1Sirolimus 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recurrence × Vinorelbine × Other solid neoplasm × Clear all
NCT00597116 2016-10-10

An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant Mesothelioma

Sanofi

Phase 2 Terminated
25 enrolled 8 charts
Other solid neoplasmThoracic

Mesothelioma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡